UHS: Q2 2026 delivered robust volume growth, updated guidance, and accelerated share repurchases
Q2 2026 featured strong acute care volume rebound, stable behavioral health trends, and disciplined expense management. Updated 2026 guidance reflects 7% revenue growth and 3% EBITDA less NCI growth, with continued capital deployment in share repurchases and capacity expansion.Based on Universal He…